May 25, 2026

Hercules Plc reports robust FY25 growth, says latest SP Angel research note

Hercules Plc delivered FY25 revenue growth, improved EBITDA and expanded market opportunities, according to the latest research note from SP Angel...

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 36% Potential Upside in Biotechnology

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading name in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to healthcare innovation. With a market capitalization of $10.45 billion, the..

Nuvalent, Inc. (NUVL) Stock Analysis: Evaluating a Potential 41.52% Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors with its robust pipeline of innovative cancer therapies and a notable potential upside of 41.52%. The clinical-stage biopharmaceutical company, based..

Charles River Laboratories Inte (CRL) Stock Analysis: A 30% Upside Potential Amidst Healthcare Sector Dynamics

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a robust market capitalization of $7.72..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 103% Potential Upside with Robust Revenue Growth

Investors with a keen eye on the biotechnology sector should not overlook ADMA Biologics Inc (NASDAQ: ADMA), a company that presents an intriguing investment opportunity in the healthcare industry. With..

Guardant Health, Inc. (GH) Stock Analysis: 48.3% Revenue Growth Fuels Investor Optimism

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, presents a compelling opportunity for investors captivated by the intersection of healthcare and cutting-edge technology. With a market capitalization of..

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 36% Upside Potential Amidst a Challenging Healthcare Landscape

Grifols, S.A. (NASDAQ: GRFS), a renowned player in the healthcare sector, particularly in the drug manufacturing industry, is capturing the attention of investors due to its notable market position and..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking a 130% Potential Upside in the Biotech Sector

Investors seeking opportunities in the dynamic biotechnology sector should pay close attention to Vaxcyte, Inc. (NASDAQ: PCVX). As a clinical-stage vaccine innovation company, Vaxcyte is making significant strides in developing..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth in the Healthcare Sector with a Strong Return on Equity

As Masimo Corporation (NASDAQ: MASI) continues to navigate the complex healthcare landscape, investors are keeping a close eye on this medical device giant. With a market capitalization of $9.36 billion,..

Alkermes plc (ALKS) Stock Analysis: Unlocking Potential with a 23.47% Upside

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, has been gaining attention in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

BrightSpring Health Services (BTSG) Stock Report: A Healthcare Giant with a 4.96% Potential Upside

BrightSpring Health Services, Inc. (BTSG) is capturing the attention of investors with its impressive market presence and robust analyst ratings. Headquartered in Louisville, Kentucky, BrightSpring specializes in home and community-based..

Elanco Animal Health (ELAN) Stock Analysis: Exploring Potential 37% Upside with Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the drug manufacturers’ landscape focused on specialty and generic solutions. With a market..

Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point to a Promising 26% Upside

Doximity, Inc. (NYSE: DOCS), a leader in the Health Information Services industry, is making waves in the healthcare sector with its innovative digital platform tailored for medical professionals. As the..

Soleno Therapeutics (SLNO) Investor Outlook: Navigating the Hold Ratings with Promising EPS and Cash Flow

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a pioneering biopharmaceutical company, has carved a niche in the biotechnology sector with its focus on developing therapeutics for rare diseases. Headquartered in Redwood City,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 57% Upside Potential in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention in the biotechnology sector with its impressive potential for growth. Known for focusing on rare neuroendocrine diseases, this Boston-based company is..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unpacking a Potential 13% Upside for Investors

Bausch + Lomb Corporation (NYSE: BLCO) stands as a venerable name in the eye health industry, with roots dating back to 1853. As a subsidiary of Bausch Health Companies Inc.,..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 55% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is catching the eye of investors with its substantial growth potential...

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Highlights 33.56% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is garnering attention from investors due to its compelling growth prospects in the biotechnology sector. With a market capitalization of $12.49 billion, Ionis is a..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Through a 52.6% Revenue Growth Amidst a Challenging Valuation Landscape

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare sector, has been making waves with its innovative approach to health insurance. As a healthcare technology company, Oscar Health..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 24.45% Potential Upside in Healthcare Innovation

For investors seeking opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing proposition. With a market capitalization of $25.66 billion, this Dutch healthcare giant operates across..

Search

Funds

May 25, 2026

Hercules Plc reports robust FY25 growth, says latest SP Angel research note

Hercules Plc delivered FY25 revenue growth, improved EBITDA and expanded market opportunities, according to the latest research note from SP Angel...
Search

Funds

May 25, 2026

FTSE 100

Funds